Amit Singh

1.7k total citations · 1 hit paper
15 papers, 1.3k citations indexed

About

Amit Singh is a scholar working on Molecular Biology, Biomaterials and Cancer Research. According to data from OpenAlex, Amit Singh has authored 15 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 8 papers in Biomaterials and 5 papers in Cancer Research. Recurrent topics in Amit Singh's work include Nanoparticle-Based Drug Delivery (8 papers), RNA Interference and Gene Delivery (5 papers) and Cancer Research and Treatments (3 papers). Amit Singh is often cited by papers focused on Nanoparticle-Based Drug Delivery (8 papers), RNA Interference and Gene Delivery (5 papers) and Cancer Research and Treatments (3 papers). Amit Singh collaborates with scholars based in United States, Australia and Chile. Amit Singh's co-authors include Mansoor M. Amiji, George Mattheolabakis, Lara Milane, Srinivas Ganta, Arun K. Iyer, Meghna Talekar, Jing Xu, Ana Vanessa Nascimento, Domingos Ferreira and Bruno Sarmento and has published in prestigious journals such as Advanced Drug Delivery Reviews, Scientific Reports and Acta Biomaterialia.

In The Last Decade

Amit Singh

15 papers receiving 1.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Hyaluronic acid targeting of CD44 for cancer therapy: from receptor biology to nanomedicine

2015 454 citations George Mattheolabakis, Lara Milane et al. Journal of drug targeting profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Amit Singh United States	15	608	604	482	218	166	15	1.3k
Xu Song China	20	630 1.0×	487 0.8×	505 1.0×	163 0.7×	140 0.8×	57	1.4k
Sang Mun Bae South Korea	18	742 1.2×	858 1.4×	622 1.3×	168 0.8×	118 0.7×	26	1.8k
Dawn Waterhouse Canada	20	704 1.2×	568 0.9×	360 0.7×	308 1.4×	121 0.7×	36	1.4k
Aeju Lee South Korea	23	681 1.1×	401 0.7×	569 1.2×	160 0.7×	179 1.1×	38	1.4k
Sanyogitta Puri United Kingdom	14	734 1.2×	726 1.2×	639 1.3×	140 0.6×	82 0.5×	20	1.6k
Edgar Pérez‐Herrero Spain	16	707 1.2×	771 1.3×	760 1.6×	252 1.2×	133 0.8×	21	1.9k
Imran Vhora India	21	877 1.4×	617 1.0×	386 0.8×	325 1.5×	108 0.7×	25	1.8k
Seung Woo Chung South Korea	20	493 0.8×	270 0.4×	290 0.6×	257 1.2×	118 0.7×	47	1.0k
Sharon A. Johnstone Canada	15	993 1.6×	850 1.4×	450 0.9×	251 1.2×	83 0.5×	20	1.7k
Sara Zalba Spain	17	604 1.0×	520 0.9×	370 0.8×	204 0.9×	94 0.6×	29	1.2k

Countries citing papers authored by Amit Singh

Since Specialization

Citations

This map shows the geographic impact of Amit Singh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amit Singh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amit Singh more than expected).

Fields of papers citing papers by Amit Singh

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amit Singh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amit Singh. The network helps show where Amit Singh may publish in the future.

Co-authorship network of co-authors of Amit Singh

This figure shows the co-authorship network connecting the top 25 collaborators of Amit Singh. A scholar is included among the top collaborators of Amit Singh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amit Singh. Amit Singh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Taha, Maie S., Smrithi Padmakumar, Amit Singh, & Mansoor M. Amiji. (2020). Critical quality attributes in the development of therapeutic nanomedicines toward clinical translation. Drug Delivery and Translational Research. 10(3). 766–790. 35 indexed citations

Singh, Amit, et al.. (2019). Quality-by-Design Concepts to Improve Nanotechnology-Based Drug Development. Pharmaceutical Research. 36(11). 153–153. 71 indexed citations

Trivedi, Malav, et al.. (2017). MicroRNA-34a Encapsulated in Hyaluronic Acid Nanoparticles Induces Epigenetic Changes with Altered Mitochondrial Bioenergetics and Apoptosis in Non-Small-Cell Lung Cancer Cells. Scientific Reports. 7(1). 3636–3636. 30 indexed citations

Nascimento, Ana Vanessa, Amit Singh, Hassan Bousbaa, et al.. (2016). Overcoming cisplatin resistance in non-small cell lung cancer with Mad2 silencing siRNA delivered systemically using EGFR-targeted chitosan nanoparticles. Acta Biomaterialia. 47. 71–80. 98 indexed citations

Amiji, Mansoor M., Srujan Gandham, Meghna Talekar, & Amit Singh. (2015). Inhibition of hexokinase-2 with targeted liposomal 3-bromopyruvate in an ovarian tumor spheroid model of aerobic glycolysis. International Journal of Nanomedicine. 10. 4405–4405. 31 indexed citations

Mattheolabakis, George, Lara Milane, Amit Singh, & Mansoor M. Amiji. (2015). Hyaluronic acid targeting of CD44 for cancer therapy: from receptor biology to nanomedicine. Journal of drug targeting. 23(7-8). 605–618. 454 indexed citations breakdown →

Singh, Amit, Jing Xu, George Mattheolabakis, & Mansoor M. Amiji. (2015). EGFR-targeted gelatin nanoparticles for systemic administration of gemcitabine in an orthotopic pancreatic cancer model. Nanomedicine Nanotechnology Biology and Medicine. 12(3). 589–600. 50 indexed citations

Ganta, Srinivas, Amit Singh, Praveen Kulkarni, et al.. (2015). EGFR Targeted Theranostic Nanoemulsion for Image-Guided Ovarian Cancer Therapy. Pharmaceutical Research. 32(8). 2753–63. 26 indexed citations

Ganta, Srinivas, Amit Singh, Niravkumar R. Patel, et al.. (2014). Development of EGFR-Targeted Nanoemulsion for Imaging and Novel Platinum Therapy of Ovarian Cancer. Pharmaceutical Research. 31(9). 2490–2502. 34 indexed citations

10.

Yang, Xiaoqian, Arun K. Iyer, Amit Singh, et al.. (2014). Cluster of Differentiation 44 Targeted Hyaluronic Acid Based Nanoparticles for MDR1 siRNA Delivery to Overcome Drug Resistance in Ovarian Cancer. Pharmaceutical Research. 32(6). 2097–2109. 69 indexed citations

11.

Talekar, Meghna, Srinivas Reddy Boreddy, Amit Singh, & Mansoor M. Amiji. (2014). Tumor aerobic glycolysis: new insights into therapeutic strategies with targeted delivery. Expert Opinion on Biological Therapy. 14(8). 1145–1159. 36 indexed citations

12.

Xu, Jing, Amit Singh, & Mansoor M. Amiji. (2014). Redox-responsive targeted gelatin nanoparticles for delivery of combination wt-p53 expressing plasmid DNA and gemcitabine in the treatment of pancreatic cancer. BMC Cancer. 14(1). 75–75. 52 indexed citations

13.

Singh, Amit, et al.. (2014). Combinatorial approach in the design of multifunctional polymeric nano-delivery systems for cancer therapy. Journal of Materials Chemistry B. 2(46). 8069–8084. 51 indexed citations

14.

Iyer, Arun K., Amit Singh, Srinivas Ganta, & Mansoor M. Amiji. (2013). Role of integrated cancer nanomedicine in overcoming drug resistance. Advanced Drug Delivery Reviews. 65(13-14). 1784–1802. 278 indexed citations

15.

Talekar, Meghna, Srinivas Ganta, Amit Singh, et al.. (2012). Phosphatidylinositol 3-kinase Inhibitor (PIK75) Containing Surface Functionalized Nanoemulsion for Enhanced Drug Delivery, Cytotoxicity and Pro-apoptotic Activity in Ovarian Cancer Cells. Pharmaceutical Research. 29(10). 2874–2886. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact